All posts by Robin Lynn White

Q&A with Dr. Sergio Rutella: Multi-analyte studies in acute myeloid leukemia

Sergio Rutella, M.D., Ph.D. FRCPath is a Professor of Cancer Immunotherapy at the John van Geest Cancer Research Centre at Nottingham Trent University. His research focuses on acute myeloid leukemia (AML), an aggressive form of cancer that originates in the...

/ December 14, 2017

Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma

David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such as multiple myeloma and lymphoma. His research centers on the...

/ November 16, 2017

Getting More from Flow Cytometry

Immunology studies rely on identifying unique cell populations, such as T cells and B cells, and then analyzing these cells to understand the biology of these cells. Studying different types of immune cells has provided insight into many fields, such...

/ October 2, 2017

Multi-Analyte Analysis of Lung Cancer FFPE Samples with 3D Biology™ Technology

NanoString sat down with McGarry Houghton, M.D., Associate Member of the Clinical Research and Human Biology Divisions at Fred Hutch Cancer Research Center, to discuss how his lab is using 3D Biology™ Technology to advance understanding of the lung tumor...

/ June 1, 2017
3Dbiology_Banner

Researcher Profiles: How NanoString® Grant Program Winners are Utilizing 3D Biology™ Technology

This past February, four grant program applicants were awarded nCounter Vantage 3D™ Assays of their choice to profile 36 samples. NanoString followed up with each of the winners to explore how they intend to use the assays to advance their...

/ May 8, 2017